United Therapeutics Corporation

United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of products to address the medical needs of patients with chronic and cardiovascular, and infectious diseases and cancer. The Company's principal therapeutic platforms include Prostacyclin Analogs, Phosphodiesterase 5 (PDE5) inhibitors, Glycobiology Antiviral Agents and Monoclonal Antibodies. Its principal prostacyclin analog is Remodulin, a treprostinil-based compound for the treatment of cardiovascular disease. Remodulin (treprostinil sodium) Injection, has been approved by the United States ...


There are no scholarships at this time


There are no events at this time

Company Data on United Therapeutics Corporation
provided by Owler


United Therapeutics Corporation is hiring for these positions

Show me: All available jobs